2023 - Research.com Immunology in Israel Leader Award
2022 - Research.com Immunology in Israel Leader Award
1989 - Fellow of the American Association for the Advancement of Science (AAAS)
1976 - Member of the National Academy of Sciences
1971 - Fellow of the American Academy of Arts and Sciences
Member of the European Academy of Sciences and Arts
Michael Sela mainly focuses on Biochemistry, Molecular biology, Antibody, Antigen and Immunology. His work deals with themes such as Antigenicity and Immunogenicity, which intersect with Biochemistry. His work carried out in the field of Molecular biology brings together such families of science as Cell, Antigen-presenting cell, Myelin basic protein, Receptor tyrosine kinase and Epitope.
The Monoclonal antibody research Michael Sela does as part of his general Antibody study is frequently linked to other disciplines of science, such as Conjugate, therefore creating a link between diverse domains of science. His Monoclonal antibody study combines topics in areas such as Receptor, Epidermal growth factor, Epidermal growth factor receptor, ErbB and Cell growth. His Antigen research incorporates themes from Autoimmunity, Gene and Bovine serum albumin.
His primary areas of investigation include Antibody, Biochemistry, Molecular biology, Antigen and Immunology. His Antibody research focuses on subjects like In vitro, which are linked to In vivo. His study in Amino acid, Alanine, Peptide, Ribonuclease and Bovine serum albumin is carried out as part of his Biochemistry studies.
In his study, which falls under the umbrella issue of Molecular biology, Acetylcholine receptor is strongly linked to T cell. As part of one scientific family, he deals mainly with the area of Antigen, narrowing it down to issues related to the Tyrosine, and often Glutamic acid. His study ties his expertise on Myelin basic protein together with the subject of Immunology.
The scientist’s investigation covers issues in Immunology, Multiple sclerosis, Molecular biology, T cell and Experimental autoimmune encephalomyelitis. His work is dedicated to discovering how Immunology, Myelin basic protein are connected with Adoptive cell transfer and other disciplines. His studies in Molecular biology integrate themes in fields like Receptor, Biochemistry, Peptide, Epitope and Monoclonal antibody.
His Biochemistry research is mostly focused on the topic Amino acid. His Antibody research includes elements of Endocytosis and Immunotherapy. Immune system connects with themes related to Antigen in his study.
His primary scientific interests are in Immunology, Multiple sclerosis, T cell, Experimental autoimmune encephalomyelitis and Molecular biology. In his work, Adoptive cell transfer and Cytokine is strongly intertwined with Myelin basic protein, which is a subfield of Immunology. His Multiple sclerosis research is multidisciplinary, incorporating perspectives in Autoimmunity, Pharmacology and Antigen.
His T cell research includes themes of Biochemistry, CD8, Spleen, Major histocompatibility complex and FOXP3. His Molecular biology research is multidisciplinary, relying on both Cancer research and Receptor tyrosine kinase, Signal transduction, ErbB. His Antibody study focuses on Monoclonal antibody in particular.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
THE KINETICS OF FORMATION OF NATIVE RIBONUCLEASE DURING OXIDATION OF THE REDUCED POLYPEPTIDE CHAIN
Christian B. Anfinsen;Edgar Haber;Michael Sela;F. H. White.
Proceedings of the National Academy of Sciences of the United States of America (1961)
Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.
R Pinkas-Kramarski;L Soussan;H Waterman;G Levkowitz.
The EMBO Journal (1996)
Biochemical and clinical implications of the ErbB/HER signaling network of growth factor receptors.
L N Klapper;M H Kirschbaum;M Sela;Y Yarden.
Advances in Cancer Research (2000)
Mechanistic aspects of the opposing effects of monoclonal antibodies to the ERBB2 receptor on tumor growth
Ilana Stancovski;Esther Hurwitz;Orit Leitner;Axel Ullrich.
Proceedings of the National Academy of Sciences of the United States of America (1991)
Suppression of experimental allergic encephalomyelitis by a synthetic polypeptide.
Dvora Teitelbaum;A. Meshorer;T. Hirshfeld;Ruth Arnon.
European Journal of Immunology (1971)
The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors
Leah N. Klapper;Stefanie Glathe;Nora Vaisman;Nancy E. Hynes.
Proceedings of the National Academy of Sciences of the United States of America (1999)
A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis
Bornstein Mb;Miller A;Slagle S;Weitzman M.
The New England Journal of Medicine (1987)
Antigenicity: some molecular aspects.
Differential endocytic routing of homo- and hetero-dimeric ErbB tyrosine kinases confers signaling superiority to receptor heterodimers.
Anne E.G. Lenferink;Ronit Pinkas‐Kramarski;Monique L.M. van de Poll;Marianne J.H. van Vugt.
The EMBO Journal (1998)
Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice.
Hugh O. McDevitt;Michael Sela.
Journal of Experimental Medicine (1965)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: